Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M. John Novak is active.

Publication


Featured researches published by M. John Novak.


Clinical Chemistry | 2009

Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: A feasibility study

Pierre N. Floriano; Nicolaos Christodoulides; Craig S. Miller; Jeffrey L. Ebersole; John A. Spertus; Beate G. Rose; Denis F. Kinane; M. John Novak; Steven R. Steinhubl; Shelley Acosta; Sanghamitra Mohanty; Priya Dharshan; Chih Ko Yeh; Spencer W. Redding; Wieslaw B. Furmaga; John T. McDevitt

BACKGROUND For adults with chest pain, the electrocardiogram (ECG) and measures of serum biomarkers are used to screen and diagnose myocardial necrosis. These measurements require time that can delay therapy and affect prognosis. Our objective was to investigate the feasibility and utility of saliva as an alternative diagnostic fluid for identifying biomarkers of acute myocardial infarction (AMI). METHODS We used Luminex and lab-on-a-chip methods to assay 21 proteins in serum and unstimulated whole saliva procured from 41 AMI patients within 48 h of chest pain onset and from 43 apparently healthy controls. Data were analyzed by use of logistic regression and area under curve (AUC) for ROC analysis to evaluate the diagnostic utility of each biomarker, or combinations of biomarkers, in screening for AMI. RESULTS Both established and novel cardiac biomarkers demonstrated significant differences in concentrations between patients with AMI and controls without AMI. The saliva-based biomarker panel of C-reactive protein, myoglobin, and myeloperoxidase exhibited significant diagnostic capability (AUC = 0.85, P < 0.0001) and in conjunction with ECG yielded strong screening capacity for AMI (AUC = 0.96) comparable to that of the panel (brain natriuretic peptide, troponin-I, creatine kinase-MB, myoglobin; AUC = 0.98) and far exceeded the screening capacity of ECG alone (AUC approximately 0.6). En route to translating these findings to clinical practice, we adapted these unstimulated whole saliva tests to a novel lab-on-a-chip platform for proof-of-principle screens for AMI. CONCLUSIONS Complementary to ECG, saliva-based tests within lab-on-a-chip systems may provide a convenient and rapid screening method for cardiac events in prehospital stages for AMI patients.


Journal of Periodontology | 2009

Serum Inflammatory Mediators in Pregnancy: Changes After Periodontal Treatment and Association With Pregnancy Outcomes

Bryan S. Michalowicz; M. John Novak; James S. Hodges; Anthony J. DiAngelis; William Buchanan; Panos N. Papapanou; Dennis A. Mitchell; James E. Ferguson; Virginia R. Lupo; James A. Bofill; Stephen Matseoane; Michelle J. Steffen; Jeffrey L. Ebersole

BACKGROUND The purposes of this study were to determine: 1) if periodontal treatment in pregnant women before 21 weeks of gestation alters levels of inflammatory mediators in serum; and 2) if changes in these mediators are associated with birth outcomes. METHODS A total of 823 pregnant women with periodontitis were randomly assigned to receive scaling and root planing before 21 weeks of gestation or after delivery. Serum obtained between 13 and 16 weeks, 6 days (study baseline) and 29 to 32 weeks of gestation was analyzed for C-reactive protein; prostaglandin E(2); matrix metalloproteinase-9; fibrinogen; endotoxin; interleukin (IL)-1 beta, -6, and -8, and tumor necrosis factor-alpha. Cox regression, multiple linear regression, and the t, chi(2), and Fisher exact tests were used to examine associations among the biomarkers, periodontal treatment, and gestational age at delivery and birth weight. RESULTS A total of 796 women had baseline serum data, and 620 women had baseline and follow-up serum and birth data. Periodontal treatment did not significantly alter the level of any biomarker (P >0.05). Neither baseline levels nor the change from baseline in any biomarker were significantly associated with preterm birth or infant birth weight (P >0.05). In treatment subjects, the change in endotoxin was negatively associated with the change in probing depth (P <0.05). CONCLUSIONS Non-surgical mechanical periodontal treatment in pregnant women, delivered before 21 weeks of gestation, did not reduce systemic (serum) markers of inflammation. In pregnant women with periodontitis, levels of these markers at 13 to 17 weeks and 29 to 32 weeks of gestation were not associated with infant birth weight or a risk for preterm birth.


Journal of Periodontology | 2009

Systemic Immune Responses in Pregnancy and Periodontitis: Relationship to Pregnancy Outcomes in the Obstetrics and Periodontal Therapy (OPT) Study

Jeffrey L. Ebersole; M. John Novak; Bryan S. Michalowicz; James S. Hodges; Michelle J. Steffen; James E. Ferguson; Anthony J. DiAngelis; William Buchanan; Dennis A. Mitchell; Panos N. Papapanou

BACKGROUND Our previous studies reported on the obstetric, periodontal, and microbiologic outcomes of women participating in the Obstetrics and Periodontal Therapy (OPT) Study. This article describes the systemic antibody responses to selected periodontal bacteria in the same patients. METHODS Serum samples, obtained from pregnant women at baseline (13 to 16 weeks; 6 days of gestation) and 29 to 32 weeks, were analyzed by enzyme-linked immunosorbent assay for serum immunoglobulin G (IgG) antibody to Aggregatibacter actinomycetemcomitans (previously Actinobacillus actinomycetemcomitans), Campylobacter rectus, Fusobacterium nucleatum, Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia (previously T. forsythensis), and Treponema denticola. RESULTS At baseline, women who delivered live preterm infants had significantly lower total serum levels of IgG antibody to the panel of periodontal pathogens (P = 0.0018), to P. gingivalis (P = 0.0013), and to F. nucleatum (P = 0.0200) than women who delivered at term. These differences were not significant at 29 to 32 weeks. Changes in IgG levels between baseline and 29 to 32 weeks were not associated with preterm birth when adjusted for treatment group, clinical center, race, or age. In addition, delivery of low birth weight infants was not associated with levels of antibody at baseline or with antibody changes during pregnancy. CONCLUSIONS Live preterm birth is associated with decreased levels of IgG antibody to periodontal pathogens in women with periodontitis when assessed during the second trimester. Changes in IgG antibody during pregnancy are not associated with birth outcomes.


Nutrition | 2009

Effects of caloric restriction on inflammatory periodontal disease

Mark A. Reynolds; Dolphus R. Dawson; Karen F. Novak; Jeffrey L. Ebersole; John C. Gunsolley; Grishondra L. Branch-Mays; Stanley C. Holt; Julie A. Mattison; Donald K. Ingram; M. John Novak

OBJECTIVE Dietary caloric restriction (CR) has been found to reduce systemic markers of inflammation and may attenuate the effects of chronic inflammatory conditions. The purpose of this study was to examine the effects of long-term CR on naturally occurring chronic inflammatory periodontal disease in a nonhuman primate model. METHODS The effects of long-term CR on extent and severity of naturally occurring chronic periodontal disease, local inflammatory and immune responses, and periodontal microbiology, were evaluated in a cohort of 81 (35 female and 46 male; 13-40 y of age) rhesus monkeys (Macaca mulatta) with no previous exposure to routine oral hygiene. CR monkeys had been subjected to 30% CR for 13-17 y relative to control-fed (CON) animals starting at 3-5 y of age. RESULTS Same sex CR and CON monkeys exhibited similar levels of plaque, calculus, and bleeding on probing. Among CON animals, males showed significantly greater periodontal breakdown, as reflected by higher mean clinical attachment level and periodontal probing depth scores, than females. CR males exhibited significantly less periodontal pocketing, lower IgG antibody response, and lower IL-8 and ss-glucuronidase levels compared to CON males, whereas CR females showed a lower IgG antibody response but comparable clinical parameters and inflammatory marker levels relative to CON females. Long-term CR had no demonstrable effect on the periodontal microbiota. CONCLUSION Males demonstrated greater risk for naturally occurring periodontal disease than females. Long-term CR may differentially reduce the production of local inflammatory mediators and risk for inflammatory periodontal disease among males but not females.


Clinical Obstetrics and Gynecology | 2007

Should we treat periodontal disease during gestation to improve pregnancy outcomes

James E. Ferguson; Wendy Hansen; Karen F. Novak; M. John Novak

Until recently many physicians in the United States including obstetrician gynecologists have been relatively unconcerned with oral health. During most physical examinations, the oral cavity is given only a rudimentary examination. With the recognition of the oral-systemic health care link, physicians have been keenly interested in the findings from their dental colleagues in periodontal medicine which have convincingly linked periodontal disease with such diverse systemic health complications as aging, Alzheimer disease, cardiovascular disease, diabetes, and also pregnancy complications including low birth weight, preterm delivery, preeclampsia, and early pregnancy loss. Intervention trials designed to improve oral health during pregnancy have proven to be safe; however, the outcomes have been inconsistent. Further studies will be required to determine the nature of the association and the optimal timing and efficacy of intervention.


Frontiers in Immunology | 2016

Transcriptome Analysis of B Cell Immune Functions in Periodontitis: Mucosal Tissue Responses to the Oral Microbiome in Aging

Jeffrey L. Ebersole; Sreenatha Kirakodu; M. John Novak; Luis Orraca; Janis Gonzalez Martinez; Larry L. Cunningham; Mark V. Thomas; Arnold J. Stromberg; Subramanya N. Pandruvada; Octavio A. Gonzalez

Evidence has shown activation of T and B cells in gingival tissues in experimental models and in humans diagnosed with periodontitis. The results of this adaptive immune response are noted both locally and systemically with antigenic specificity for an array of oral bacteria, including periodontopathic species, e.g., Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. It has been recognized through epidemiological studies and clinical observations that the prevalence of periodontitis increases with age. This report describes our studies evaluating gingival tissue transcriptomes in humans and specifically exploiting the use of a non-human primate model of naturally occurring periodontitis to delineate gingival mucosal tissue gene expression profiles focusing on cells/genes critical for the development of humoral adaptive immune responses. Patterns of B cell and plasmacyte genes were altered in aging healthy gingival tissues. Substantial increases in a large number of genes reflecting antigen-dependent activation, B cell activation, B cell proliferation, and B cell differentiation/maturation were observed in periodontitis in adults and aged animals. Finally, evaluation of the relationship of these gene expression patterns with those of various tissue destructive molecules (MMP2, MMP9, CTSK, TNFα, and RANKL) showed a greater frequency of positive correlations in healthy tissues versus periodontitis tissues, with only MMP9 correlations similar between the two tissue types. These results are consistent with B cell response activities in healthy tissues potentially contributing to muting the effects of the tissue destructive biomolecules, whereas with periodontitis this relationship is adversely affected and enabling a progression of tissue destructive events.


Pharmacological Research | 2011

Inflammation: Friend or foe?

M. John Novak

For over 2000 years, the importance of inflammation in the efense of the body has been a focus of attention. The chemial and cellular mechanisms involved in protecting humans from ttack have been clearly defined and defects identified that may ead to invaders gaining an advantage over the host’s defenses. At he same time, it has been observed that the battle between the ost’s inflammatory response and the invader may lead to celular and tissue damage that can result in long term pathologic njury to cells, tissues, and organs. Furthermore, increasing evience is accumulating that indicates a significant diversity in the nflammatory response between individuals that can be worsened y genetic predisposition and/or environmental influences. The esulting ‘hyper-inflammatory’ phenotype and/or genotype have ome under considerable scientific scrutiny and polymorphisms n proand anti-inflammatory genes that can influence the magitude of the inflammatory response have been characterized. In ddition, environmental factors such as increased dietary fats and ugars, exposure to nicotine containing products, and increased nxiety and stress may all lead to an alteration in the magnitude nd duration of the inflammatory response. As a result, an exaggerted or dysregulated inflammatory response has been linked to the evelopment of pathologic changes associated with several chronic onditions including cardiovascular disease, Alzheimer’s disease, ancer, diabetes, osteoporotic and osteopenic bone loss, skin conitions such as acne and rosacea, and periodontal disease to name ut a few of the currently known inflammatory diseases. With an increased understanding of the etiology of chronic nflammatory conditions comes the development of new strateies for inflammatory control in an attempt to reduce the tissue amage that frequently accompanies the body’s attempt to proect itself. Many of the new strategies have come as a result of


The New England Journal of Medicine | 2006

Treatment of Periodontal Disease and the Risk of Preterm Birth

Bryan S. Michalowicz; James S. Hodges; Anthony J. DiAngelis; Virginia R. Lupo; M. John Novak; James E. Ferguson; William Buchanan; James A. Bofill; Panos N. Papapanou; Dennis A. Mitchell; Stephen Matseoane; Pat A. Tschida


Journal of Periodontology | 2002

Adjunctive Benefits of Subantimicrobial Dose Doxycycline in the Management of Severe, Generalized, Chronic Periodontitis

M. John Novak; Lee P. Johns; Renee C. Miller; Mark Bradshaw


Journal of the American Dental Association | 2008

Examining the safety of dental treatment in pregnant women

Bryan S. Michalowicz; Anthony J. DiAngelis; M. John Novak; William Buchanan; Panos N. Papapanou; Dennis A. Mitchell; Alice E. Curran; Virginia R. Lupo; James E. Ferguson; James A. Bofill; Stephen Matseoane; Amos S. Deinard; Tyson Rogers

Collaboration


Dive into the M. John Novak's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anthony J. DiAngelis

Hennepin County Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alan M. Polson

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge